Group One Trading’s Petros Pharmaceuticals PTPI Stock Holding History

Group One Trading’s Portfolio PTPI Stock Details PTPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3	Closed	-$5	–	8523
2025 Q1	$5	Hold	3	–	–	﹤0.01%	7461
2024 Q4	$31	Hold	3	–	–	﹤0.01%	7135
2024 Q3	$28	Hold	3	–	–	﹤0.01%	6512
2024 Q2	$36	Hold	3	–	–	﹤0.01%	6579
2024 Q1	$117	Hold	3	–	–	﹤0.01%	6838
2023 Q4	$112	Hold	3	–	–	﹤0.01%	7191
2023 Q3	$131	Hold	3	–	–	﹤0.01%	7458
2023 Q2	$160	Buy	+3	New	+$234	﹤0.01%	7484

Group One Trading's PTPI Position: Q2 2025 in Review

Group One Trading sold out of Petros Pharmaceuticals (PTPI) in Q2 2025, closing a stake of 3 shares — an estimated $5 sold.

Group One Trading first reported a position in PTPI in Q2 2023 and held it in 8 quarters. The position peaked at $160 in Q2 2023. 0 funds tracked by Wall St. Rank hold PTPI as of Q2 2025.

Group One Trading reported no remaining Petros Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
Group One Trading sold 3 Petros Pharmaceuticals shares in Q2 2025, an estimated $5.
Group One Trading first reported a position in Petros Pharmaceuticals in Q2 2023 and held it in 8 quarters.
Group One Trading's Petros Pharmaceuticals position peaked at $160 in Q2 2023.
0 funds tracked by Wall St. Rank held Petros Pharmaceuticals as of Q2 2025.

Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.